Author

N. Rufo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:biophysical modeling· 1 Assay:bulk RNA-seq· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. D. Garg· 1 shared D. Korovesis· 1 shared F. Finotello· 1 shared J. Rozanc· 1 shared L. Alexopoulos· 1 shared L. Sinkkonen· 1 shared M. Dewaele· 1 shared M. Vara Perez· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. D. Garg

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The IRE1 Inhibitor KIRA6 Curtails The Inflammatory Trait Of Immunogenic Anticancer Treatments By Targeting HSP60 Independent Of IRE1

N. Rufo, D. Korovesis, S. van Eygen, R. Derua, A. D. Garg, F. Finotello, M. Vara Perez, J. Rozanc, M. Dewaele, P. A. de Witte, L. Alexopoulos, S. Janssens, L. Sinkkonen, T. Sauter, S. H. L. Verhelst, P. Agostinis

The paper shows KIRA6 reduces inflammation from immunogenic cancer treatments by targeting HSP60, not through IRE1 inhibition.

bioRxiv · Dec 24, 2020 · PreprintCancer Biology